# ClinicalTrials.gov record NCT01982240

> PeptideScanner retained ClinicalTrials.gov record NCT01982240 at 2026-07-30T20:42:14.439Z. Its registry update date was 2019-12-26, and PeptideScanner's reviewed identity mapping was plecanatide.

- Evidence object: `story:clinicaltrials-gov-nct01982240-plecanatide:v1`
- Evidence domain: Clinical trials
- Date in source: 2019-12-26
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-09-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct01982240-plecanatide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct01982240-plecanatide-v1.json
- Content SHA-256: `0860a00032a0f7a5e4d25d56db9607fab75e9de9c75e3cee72c50d7813baa073`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT01982240 ([`ctg-observation-nct01982240-2019-12-26-51927c329559`](#source-ctg-observation-nct01982240-2019-12-26-51927c329559))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT01982240 at 2026-07-30T20:42:14.439Z. Its registry update date was 2019-12-26, and PeptideScanner's reviewed identity mapping was plecanatide. ([`ctg-observation-nct01982240-2019-12-26-51927c329559`](#source-ctg-observation-nct01982240-2019-12-26-51927c329559))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT01982240 at 2026-07-30T20:42:14.439Z. Its registry update date was 2019-12-26, and PeptideScanner's reviewed identity mapping was plecanatide. ([`ctg-observation-nct01982240-2019-12-26-51927c329559`](#source-ctg-observation-nct01982240-2019-12-26-51927c329559))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct01982240-2019-12-26-51927c329559`](#source-ctg-observation-nct01982240-2019-12-26-51927c329559))

## Sources

<a id="source-ctg-observation-nct01982240-2019-12-26-51927c329559"></a>
- **ClinicalTrials.gov record NCT01982240 · retained source version 2019-12-26:51927c3295593b54f62471da0562922cedfe729ef809fc465c7c09ffc2ce3bac** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT01982240) (`ctg-observation-nct01982240-2019-12-26-51927c329559`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT01982240." Version 1, published 2026-09-09. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct01982240-plecanatide-v1.json SHA-256: 0860a00032a0f7a5e4d25d56db9607fab75e9de9c75e3cee72c50d7813baa073.

